Structural Basis for PPARα Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Peroxisome proliferator-activated receptor α (PPARα) regulates fatty acid metabolism and is a target for dyslipidemia treatment.
• PPARα agonists, like fibrates, are used to manage lipid disorders.
• Novel PPARα activators with distinct chemical scaffolds are needed to overcome limitations of existing therapies.

Purpose of the Study:

• To determine the crystal structures of the PPARα ligand-binding domain (LBD) complexed with novel 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivatives.
• To elucidate the molecular basis for the selectivity and activity of these new PPARα agonists.
• To provide insights for the rational design of improved dyslipidemia therapeutics.

Main Methods:

• X-ray crystallography to determine the structures of PPARα-LBD in complex with 1H-pyrazolo[3,4-b]pyridine derivatives.
• Structural analysis to compare the binding modes of novel compounds with known PPARα agonists (fibrates).
• Structure-activity relationship analysis to understand the contribution of unique structural features to receptor activation and selectivity.

Main Results:

• The crystal structures revealed that 1H-pyrazolo[3,4-b]pyridine derivatives bind to PPARα, forming a canonical hydrogen-bond network essential for activation.
• A unique feature observed is the occupation of a small cavity between Ile272 and Ile354 by the phenyl side chain of the novel compounds, a region less accessed by fibrates.
• This distinct binding interaction may contribute to the observed subtype selectivity and enhanced activity.

Conclusions:

• The 1H-pyrazolo[3,4-b]pyridine scaffold represents a promising structural basis for developing potent and selective PPARα agonists.
• The unique binding mode offers a novel strategy for designing next-generation therapeutics for dyslipidemia.
• These findings advance our understanding of PPARα-ligand interactions and guide future drug discovery efforts.